MedPath

Comparison of Fractional Neodymiun-doped Yttrium Aluminium Garnet (Nd:YAG) 1,064-nm Picosecond Laser and Fractional 1,550-nm Erbium Fiber Laser in Facial Acne Scar Treatment

Phase 4
Recruiting
Conditions
Facial acne scar
Acne scar
Picosecond laser
Erbium fiber laser
Registration Number
TCTR20180307002
Lead Sponsor
Division of Dermatology, Department of medicine, Faculty of Medicine, Ramathibodi hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

- Having diagnosed with facial atrophic acne scar by Dermatologist
- Able to comply with treatment regulations and able to attend appointments assigned

Exclusion Criteria

- Having photosensitive dermatoses
- Have been using photosensitising drugs
- Having active acne vulgaris of the face
- Having a history of keloid
- Immunocompromised individual
- Underwent laser treatment of the face within 3 months
- Underwent chemical peeling of the face within 1 month
- Taking or have taken oral vitamin A derivatives within 3 months
- Using or have used topical vitamin A derivatives within 2 weeks
- Having recurrent herpes infection
- Pregnant or lactating women
- Having a history of skin cancer
- Having a history of allergy to any coal tar derivatives

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement score At 1, 2, 3, 4, 5 and 6 months Dermatologist evaluation of improvement in acne scar after each treatment
Secondary Outcome Measures
NameTimeMethod
Side effect occurance At 1, 2, 3, 4, 5 and 6 months Dermatologist evaluation and patients' feedback,Pain score Immediately after each treatment Patients' feedback through 10-point scale
© Copyright 2025. All Rights Reserved by MedPath